Geode Capital Management’s VYNE Therapeutics VYNE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$220K Sell
133,329
-161
-0.1% -$266 ﹤0.01% 3844
2025
Q1
$211K Sell
133,490
-1,527
-1% -$2.41K ﹤0.01% 3834
2024
Q4
$452K Buy
135,017
+427
+0.3% +$1.43K ﹤0.01% 3630
2024
Q3
$253K Sell
134,590
-1,080
-0.8% -$2.03K ﹤0.01% 3828
2024
Q2
$267K Buy
135,670
+28,895
+27% +$56.9K ﹤0.01% 3809
2024
Q1
$328K Buy
106,775
+12,432
+13% +$38.2K ﹤0.01% 3768
2023
Q4
$220K Buy
94,343
+66,809
+243% +$156K ﹤0.01% 3907
2023
Q3
$110K Buy
27,534
+2,589
+10% +$10.4K ﹤0.01% 4217
2023
Q2
$101K Hold
24,945
﹤0.01% 4329
2023
Q1
$76.8K Sell
24,945
-4
-0% -$12 ﹤0.01% 4423
2022
Q4
$67K Sell
24,949
-62
-0.2% -$166 ﹤0.01% 4515
2022
Q3
$100K Hold
25,011
﹤0.01% 4579
2022
Q2
$175K Sell
25,011
-1,125
-4% -$7.87K ﹤0.01% 4352
2022
Q1
$305K Hold
26,136
﹤0.01% 4173
2021
Q4
$479K Hold
26,136
﹤0.01% 4070
2021
Q3
$653K Buy
26,136
+214
+0.8% +$5.35K ﹤0.01% 3902
2021
Q2
$1.64M Sell
25,922
-14,613
-36% -$923K ﹤0.01% 3356
2021
Q1
$4.99M Buy
40,535
+8,487
+26% +$1.05M ﹤0.01% 2789
2020
Q4
$3.65M Buy
32,048
+1,806
+6% +$205K ﹤0.01% 2763
2020
Q3
$3.61M Buy
30,242
+5,089
+20% +$608K ﹤0.01% 2576
2020
Q2
$3.13M Buy
25,153
+18,583
+283% +$2.31M ﹤0.01% 2594
2020
Q1
$1.27M Buy
6,570
+4,766
+264% +$919K ﹤0.01% 2912
2019
Q4
$602K Buy
1,804
+83
+5% +$27.7K ﹤0.01% 3445
2019
Q3
$555K Buy
1,721
+3
+0.2% +$967 ﹤0.01% 3439
2019
Q2
$740K Buy
1,718
+479
+39% +$206K ﹤0.01% 3327
2019
Q1
$700K Buy
1,239
+67
+6% +$37.9K ﹤0.01% 3302
2018
Q4
$347K Buy
1,172
+50
+4% +$14.8K ﹤0.01% 3497
2018
Q3
$795K Buy
1,122
+167
+17% +$118K ﹤0.01% 3310
2018
Q2
$558K Buy
955
+54
+6% +$31.6K ﹤0.01% 3397
2018
Q1
$2.44M Buy
+901
New +$2.44M ﹤0.01% 2656